Cargando…
To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and abnormal fatigability due to the antibodies against postsynaptic receptors. Despite the individual discrepancy, patients with MG share common muscle weakness, autoimmune dysfunction, and immunosuppressive treatment,...
Autores principales: | Zhou, Qian, Zhou, Ran, Yang, Haojun, Yang, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485039/ https://www.ncbi.nlm.nih.gov/pubmed/34603311 http://dx.doi.org/10.3389/fimmu.2021.733418 |
Ejemplares similares
-
Inflammation and autoimmune myasthenia gravis
por: Huda, Ruksana
Publicado: (2023) -
The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review
por: Peng, Siyang, et al.
Publicado: (2022) -
Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica
por: Wang, Zhen, et al.
Publicado: (2017) -
Complement Inhibitor Therapy for Myasthenia Gravis
por: Albazli, Khaled, et al.
Publicado: (2020) -
Muscle-Specific Kinase Myasthenia Gravis
por: Borges, Lucia S., et al.
Publicado: (2020)